These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16212532)

  • 21. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
    Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
    Peggs K; Verfuerth S; Pizzey A; Ainsworth J; Moss P; Mackinnon S
    Blood; 2002 Jan; 99(1):213-23. PubMed ID: 11756174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.
    Lacey SF; La Rosa C; Zhou W; Sharma MC; Martinez J; Krishnan A; Gallez-Hawkins G; Thao L; Longmate J; Spielberger R; Forman SJ; Limaye A; Zaia JA; Diamond DJ
    J Infect Dis; 2006 Nov; 194(10):1410-21. PubMed ID: 17054071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
    Yuan J; Latouche JB; Hodges J; Houghton AN; Heller G; Sadelain M; Riviere I; Young JW
    J Immunol; 2006 Feb; 176(4):2357-65. PubMed ID: 16455993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
    Bae J; Martinson JA; Klingemann HG
    Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
    Lim JB; Provenzano M; Kwon OH; Bettinotti M; Caruccio L; Nagorsen D; Stroncek D
    Exp Hematol; 2006 Mar; 34(3):296-307. PubMed ID: 16543064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infrequent occurrence of natural mutations in the pp65(495-503) epitope sequence presented by the HLA A*0201 allele among human cytomegalovirus isolates.
    Zaia JA; Gallez-Hawkins G; Li X; Yao ZQ; Lomeli N; Molinder K; La Rosa C; Diamond DJ
    J Virol; 2001 Mar; 75(5):2472-4. PubMed ID: 11160752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65.
    Hamel Y; Rohrlich P; Baron V; Bonhomme D; Rieux-Laucat F; Necker A; Lemonnier F; Ferradini L; Fischer A; Cavazzana-Calvo M
    Eur J Immunol; 2003 Mar; 33(3):760-8. PubMed ID: 12616496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of CD8+ T Cell responses to cytomegalovirus between human fetuses and their transmitter mothers.
    Pedron B; Guerin V; Jacquemard F; Munier A; Daffos F; Thulliez P; Aujard Y; Luton D; Sterkers G
    J Infect Dis; 2007 Oct; 196(7):1033-43. PubMed ID: 17763326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of host immunity to cytomegalovirus pp150 (UL32).
    La Rosa C; Wang Z; Lacey SF; Markel SF; Sharma MC; Martinez J; Lalimarmo MM; Diamond DJ
    Hum Immunol; 2005 Feb; 66(2):116-26. PubMed ID: 15694996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8+ suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide.
    Qin H; Vlad G; Cortesini R; Suciu-Foca N; Manavalan JS
    Hum Immunol; 2008 Nov; 69(11):776-80. PubMed ID: 18848854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
    Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
    J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
    Youde SJ; Dunbar PR; Evans EM; Fiander AN; Borysiewicz LK; Cerundolo V; Man S
    Cancer Res; 2000 Jan; 60(2):365-71. PubMed ID: 10667589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.
    Ogbomo H; Geiler J; Leutz A; von Kietzell K; Michaelis M; Doerr HW; Cinatl J
    Med Microbiol Immunol; 2009 Nov; 198(4):257-62. PubMed ID: 19813020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer.
    Akiyama Y; Kuzushima K; Tsurumi T; Yamaguchi K
    Immunol Lett; 2004 Sep; 95(2):199-205. PubMed ID: 15388261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules.
    Noy R; Haus-Cohen M; Oved K; Voloshin T; Reiter Y
    Mol Cancer Ther; 2015 Jun; 14(6):1327-35. PubMed ID: 25852061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.